“We must do whatever we can to ensure that vital medications get to those that need them as fast and as safely as we can.” — Dave Kelleher, CEO
At 4G Clinical, we believe the way to accelerate clinical research is by disrupting the way trials are executed. That’s why we have assembled a world-wide, world-class team of industry experts to revolutionize RTSM capabilities and services from the ground-up.
We deliver modern, flexible and validated randomization and trial supply management capabilities and services to Pharma and CROs faster than anyone else in the world.
Rapid study start-up – Delivered fast track study 87% faster than CRO quote.
Faster mid-study trial changes – Hours (simple) to 1 – 2 weeks (complex)
Customer and site-driven features and UI
Global experience (Phase 1, 2, 3) across North America, Europe, Asia, and Australia
Fulluptatium di venim sit aligeni enimus, volores ea con et, comnisc iderae nessitem autas aligni nonsernatur alitis il intionem res eum doluptios. Fulluptatium di venim sit aligeni enimus, volores ea con et, comnisc iderae nessitem autas aligni nonsernatur alitis il intionem res eum doluptios.
4G Clinical’s Senior Director of Marketing, Amy Ripston, had the opportunity to interview Renee Man, a brain cancer ...
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg? Over the last few months, we’ve seen hybrid trials ...
Using a modern technology stack allows RTSMs to be upgraded using the software industry standard: Blue/green deployment.
With Blue/Green deployment, the current RTSM (blue) is cloned to RTSM (green). The upgrades are performed on the cloned RTSM Green. This way, if anything were to go wrong during the upgrade itself, the original RTSM Blue is left untouched. Upgrades can be done in as little as 10 minutes up to 1 hour depending on the scope of the upgrade. Upgrades are scheduled ahead of time to ensure no disruption to a study (e.g. midnight on a Saturday).